VirnetX Holding Corporation — Q2 2014 Form 10-Q
Reporting period: Quarter and six months ended June 30, 2014. Unless otherwise noted, amounts are in thousands of dollars. VirnetX develops secure communications technology and relies principally on patent licensing; its GABRIEL technology was in beta testing.
Financial performance and liquidity
- Revenue: Q2 revenue was $268, versus $6 in Q2 2013; first-half revenue was $518, versus $300. First-half 2014 revenue included $500 recognized from non-refundable fees under a five-year license contract valued at $10,000. Revenue is recognized over the license term.
- Losses and expenses: Q2 net loss was $6,670 ($0.13 per share), compared with $7,029 ($0.14 per share). First-half net loss was $12,758 ($0.25 per share), versus $14,922 ($0.29 per share). First-half operating expenses fell to $13,643 from $16,408, largely due to $3,401 lower patent-litigation legal fees. Operating loss was $13,125. Gross margin is not presented.
- Cash flow: First-half operating cash use was $13,293, compared with $99 provided in 2013; the prior-period inflow included a $14,963 reduction in prepaid taxes. Investing activities provided $2,871, and financing activities provided $68. Cash declined $10,354 to $8,819.
- Liquidity and debt: Cash and cash equivalents plus available-for-sale investments totaled $25,736 at June 30, versus $38,988 at year-end 2013. Working capital was $21,660, down from $33,971. The balance sheet reports no debt; current liabilities totaled $4,965. A $3,750 non-cancellable lease payment is included in prepaid expenses.
- Other metrics: Stock-based compensation was $3,731 for the first half. The Series I warrant derivative liability was $2,255; its fair-value change produced a $309 first-half gain, but a $530 loss in Q2.
Changes versus the prior comparable period
First-half revenue rose $218 and net loss narrowed $2,164 year over year. Lower legal fees contributed to the reduction in operating expenses and losses. Cash and investments declined by $12,263 from December 31, 2013, principally due to legal costs, losses, and a non-cancellable lease obligation. First-half 2014 revenue was mainly license-fee amortization, whereas first-half 2013 included $300 of royalty revenue from settlement agreements.
Outlook, risks and unusual items
- Management stated that cash and short-term investments at June 30 were expected to fund operations, working capital, and legal expenses for the foreseeable future. No specific revenue or earnings guidance was provided.
- Management expected legal fees to remain at or increase from current levels over the next two quarters as infringement cases approach later stages, with legal costs expected to decline materially after the current court schedule is complete.
- Four patent-infringement lawsuits were pending. In an earlier Apple case, a jury had awarded more than $368 million and the court set a 0.98% ongoing royalty on specified products; appeals and other court matters remained pending. VirnetX had not recognized the jury award or royalties in its financial statements, and receipt or timing of proceeds was uncertain. The company stated that it would owe Leidos 25% of proceeds from that case after specified litigation costs.
- Key risks include dependence on successful patent licensing and enforcement, costly litigation and uncertain outcomes, patent challenges, limited current revenue, potential need for additional capital, and the possibility that FRAND licensing or planned products do not generate expected revenue. The company also cited potential volatility in reported earnings from revaluing warrants.
- Deferred tax assets were subject to a valuation allowance of approximately $20,000, reflecting management’s view that realization was uncertain given operating losses and uncertainty about future taxable income. Federal and state NOL carryforwards were approximately $34,000 and $38,000, respectively.
- Management reported disclosure controls and procedures were effective as of June 30, 2014, with no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Progress and outcomes of the Apple appeals, ongoing-royalty proceedings, and other patent cases, including whether any proceeds become collectible and when.
- Whether licensing activity expands beyond the existing agreements and the timing and concentration of future license or royalty revenue.
- Cash burn, legal spending, and management’s liquidity assessment, particularly if litigation costs or operating losses persist.
- The terms and accounting treatment of the five-year $10,000 license contract and the $3,750 lease obligation.
- The effect of warrant fair-value changes and stock-based compensation on reported results and potential dilution.